WebOct 20, 2024 · Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections including complicated skin and skin structure infections, right-sided infective endocarditis, bacteraemia, meningitis, sepsis and urinary tract infections. WebDaptomycin is a lipopeptide antibiotic with potent in vitro activity against gram-positive cocci, including Staphylococcus aureus. This study evaluated the in vitro and in vivo efficacies of daptomycin against two clinical isolates: methicillin-resistant S. aureus (MRSA) 277 (vancomycin MIC, 2 g/ml) and glycopeptide-intermedi-
Five Things To Know About Combination Therapy With …
WebAbstract: Bacteremia due to Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA), complicates the clinical course of liver transplantation and is associated with high morbidity and mortality. Intravascular catheters had been reported to be the most frequent source of MRSA bacteremia. Among bacteremic liver recipients, 26.3% ... WebMar 8, 2024 · S. aureus bacteremia, including those with right-sided endocarditis, caused by MSSA and MRSA NON-FDA APPROVED USES Endocarditis caused by … raymond andersson
Daptomycin Johns Hopkins ABX Guide - Hopkins Guides
WebOct 1, 2024 · Daptomycin is the preferred agent for invasive MRSA infections with an elevated vancomycin minimum inhibitory concentration (MIC) >2 μg/ml, as studies have … WebApr 1, 2024 · Although Staphylococcus aureus is a common cause of bacteremia, treatment options are limited. The need for new therapies is particularly urgent for methicillin-resistant S. aureus bacteremia (SAB). Ceftobiprole is an advanced-generation, broad-spectrum cephalosporin with activity against both methicillin-susceptible and … WebMay 4, 2024 · Ninety-day mortality in the daptomycin arm was 18.9% vs 17.7% in the placebo arm (P = 1.0). Conclusions: Among patients with MSSA BSIs, the … raymond and dembe